There’s been much chatter in the past few weeks about former Daniel Webster College and the city’s hope of reclaiming the ...
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine ...
The progression-free survival (PFS) hazard ratio (HR) was 0.60 (p < 0.0001) for ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy. The median PFS was 11.14 months in the ivonescimab ...
The Bishop Strachan School (BSS) has added a new chapter to its historic chapel with the recent unveiling of a remarkable ...
Spearheaded by its own Phantom 3500, Otto Aerospace envisions the future of private jet aviation without the traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback